Neurotensin increases net fluid secretion and transit rate in the small intestine of man.
In a double-blind study with six patients, who previously had undergone proctocolectomy for ulcerative colitis, the ileostomy discharge significantly increased from 110 to 295 ml X 4 h-1 during infusion of neurotensin, 3 pmol X kg-1 X min-1 for 4 h. Transit defined as the passage of a perorally ingested unabsorbable marker (polyethylene glycol, PEG 4000) was significantly increased during the last hour of neurotensin infusion. The dose of neurotensin used in this study has previously been shown to result in plasma levels of neurotensin-like immunoreactivity within the range obtained after a fatty meal. Thus, the present data indicate that neurotensin in man may exert a physiological function by increasing net fluid secretion in the small intestine as well as increasing the intestinal transit rate.
D000328:Adult; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006801:Humans; D007081:Ileostomy; D007408:Intestinal Absorption / Q000187:drug effects; D007419:Intestinal Secretions / Q000378:metabolism*; D007421:Intestine, Small / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009496:Neurotensin / Q000494:pharmacology*; D011092:Polyethylene Glycols / Q000378:metabolism; D011184:Postoperative Period; D013997:Time Factors
D009496:Neurotensin; D011092:Polyethylene Glycols